APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.
Neurobiol. Aging., Nov (2012)
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic.
Neurologist., Nov;18(6):426-9 (2012)
Longitudinal modeling of cognitive aging and the TOMM40 effect.
Alzheimers Dement., Nov;8(6):490-5 (2012)
The (Mis)diagnosis of Creutzfeldt-Jakob Disease.
Arch. Neurol., Sep:1-2 (2012)
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
Neurobiol. Aging., Dec;33(12):2950.e5-7 (2012)
Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.
Neurodegener Dis Manag., 2(2):183-195 (2012)
Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic Intervention.
J. Alzheimers Dis., Jun (2012)
Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications.
Alzheimers Res Ther., 4(3):20 (2012)
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Hum. Mol. Genet., Aug;21(15):3500-12 (2012)
Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.
Neurobiol. Aging., Dec;33(12):2723-32 (2012)
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E Îµ4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Neuroimage., May;60(4):2316-22 (2012)
A roadmap for improving healthcare service quality.
J Healthc Manag., 56(6):385-400; discussion 400-2 (2011 Nov-Dec)
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
J. Alzheimers Dis., 26 Suppl 3:321-9 (2011)
Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging.
J Clin Exp Neuropsychol., Oct;33(8):937-43 (2011)
Anxiety affects cognition differently in healthy apolipoprotein E Îµ4 homozygotes and non-carriers.
J Neuropsychiatry Clin Neurosci., 23(3):294-9 (2011)
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
Neurobiol. Aging., Apr;33(4):827.e11-9 (2012)
Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series.
Neurocase., Feb;18(1):1-12 (2012)
Semin Neurol., Apr;31(2):144-57 (2011)
Longitudinal modeling of frontal cognition in APOE Îµ4 homozygotes, heterozygotes, and noncarriers.
Neurology., Apr;76(16):1383-8 (2011)
Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination.
Arch. Neurol., Apr;68(4):525-8 (2011)
Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
Neurologist., Mar;17(2):121-3 (2011)
Cerebrovascular risk factors and preclinical memory decline in healthy APOE Îµ4 homozygotes.
Neurology., Mar;76(12):1078-84 (2011)
APOE varepsilon2 and presymptomatic stage Alzheimer disease: how much is not enough?
Neurology., Nov;75(22):1952-3 (2010)
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEÎµ4 carriers.
Neuroimage., Feb;54(3):1896-902 (2011)
Mayo Clin. Proc., Oct;85(10):878-80 (2010)
Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE Îµ4 allele, the major late-onset Alzheimer's susceptibility gene.
J. Alzheimers Dis., 22(1):307-13 (2010)
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Arch. Neurol., Apr;67(4):462-8 (2010)
Amyloid load in nondemented brains correlates with APOE e4.
Neurosci. Lett., Apr;473(3):168-71 (2010)
Off-label medication use in frontotemporal dementia.
Am J Alzheimers Dis Other Demen., Mar;25(2):128-33 (2010)
Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis.
Int J Mol Epidemiol Genet., 1(1):19-30 (2010)
Age-related memory decline and apolipoprotein E e4.
Discov Med., Aug;8(41):47-50 (2009)
Creativity: an organizational schema.
Cogn Behav Neurol., Sep;22(3):143-54 (2009)
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Neuroimage., Jan;49(1):169-76 (2010)
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
N. Engl. J. Med., Jul;361(3):255-63 (2009)
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia.
Neurologist., Jul;15(4):234-7 (2009)
Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
J Clin Psychiatry., Oct;70(10):1379-84 (2009)
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging.
J. Alzheimers Dis., 17(4):899-911 (2009)
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year.
Neurology., May;72(21):1843-9 (2009)
Linking functional and structural brain images with multivariate network analyses: a novel application of the partial least square method.
Neuroimage., Aug;47(2):602-10 (2009)
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Proc. Natl. Acad. Sci. U.S.A., Apr;106(16):6820-5 (2009)
Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire.
Dement Geriatr Cogn Disord., 27(3):260-72 (2009)
Compensation and finance in neurology.
Ann. Neurol., Nov;64(5):592-3 (2008)
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration.
Brain., Nov;131(Pt 11):2957-68 (2008)
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
PLoS Genet., 4(9):e1000193 (2008)
Evidence for an association between KIBRA and late-onset Alzheimer's disease.
Neurobiol. Aging., Jun;31(6):901-9 (2010)
Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
Arch. Neurol., Sep;65(9):1231-6 (2008)
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
Hum. Mol. Genet., Dec;17(23):3631-42 (2008)
Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.
Neurobiol. Aging., Apr;31(4):549-66 (2010)
Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases.
J. Neurosurg., May;108(5):1024-7 (2008)
Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients.
Neurologist., Mar;14(2):134-7 (2008)
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging.
Dement Geriatr Cogn Disord., 25(4):336-46 (2008)
Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.
Neuroimage., Apr;40(3):1214-21 (2008)
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.
Physiol. Genomics., Apr;33(2):240-56 (2008)
Obstructive sleep apnea, apolipoprotein E e4, and mild cognitive impairment.
Sleep Med., Dec;9(8):816-7 (2008)
Medical management of frontotemporal dementia.
Am J Alzheimers Dis Other Demen., 22(6):489-98 (2007 Dec-2008 Jan)
Longitudinal tracking of FTLD: toward developing clinical trial methodology.
Alzheimer Dis Assoc Disord., 21(4):S58-63 (2007 Oct-Dec)
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia.
Neurology., Dec;69(23):2186; author reply 2186-7 (2007)
Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects.
Arch. Neurol., Nov;64(11):1672-3 (2007)
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Arch. Neurol., Sep;64(9):1306-11 (2007)
Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging.
Dement Geriatr Cogn Disord., 24(1):55-64 (2007)
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
Neuron., Jun;54(5):713-20 (2007)
Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
Am J Psychiatry., Jun;164(6):916-21 (2007)
January 16 highlight and commentary: subspecialization within somatosensory cortex.
Neurology., May;68(22):1955; author reply 1955-6 (2007)
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.
Am. J. Hum. Genet., Apr;80(4):769-78 (2007)
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases.
Neurologist., Mar;13(2):98-101 (2007)
Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness.
Med Sci Sports Exerc., Jan;39(1):199-207 (2007)
Alzheimer's disease a century later.
J Clin Psychiatry., Nov;67(11):1784-800 (2006)
Giant cell arteritis.
Curr Pain Headache Rep., Dec;10(6):415-20 (2006)
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.
Physiol. Genomics., Feb;28(3):311-22 (2007)
Common Kibra alleles are associated with human memory performance.
Science., Oct;314(5798):475-8 (2006)
Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.
Mitochondrion., Aug;6(4):194-210 (2006)
A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior.
Sleep., Jul;29(7):927-33 (2006)
Regional network of magnetic resonance imaging gray matter volume in healthy aging.
Neuroreport., Jul;17(10):951-6 (2006)
Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease.
Arch. Neurol., May;63(5):766-8 (2006)
Current epidemiology of mild cognitive impairment and other predementia syndromes.
Am J Geriatr Psychiatry., Aug;13(8):633-44 (2005)
Cognitive frailty: Predementia syndrome and vascular risk factors.
Neurobiol. Aging., Jul;27(7):933-40 (2006)
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
Proc. Natl. Acad. Sci. U.S.A., Jun;102(23):8299-302 (2005)
Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Mov. Disord., Aug;20(8):982-8 (2005)
Vascular risk factors, incidence of MCI, and rates of progression to dementia.
Neurology., Nov;63(10):1882-91 (2004)
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy.
Neurology., Oct;63(7):1168-74 (2004)
A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes.
J Neuropsychiatry Clin Neurosci., 16(3):320-9 (2004)
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
Neurology., Jun;62(11):1990-5 (2004)
Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment.
Neuropsychologia., 42(7):980-9 (2004)
Current issues in the diagnosis and management of dementia.
Semin Neurol., Sep;23(3):231-40 (2003)
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Proc. Natl. Acad. Sci. U.S.A., Jan;101(1):284-9 (2004)